Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice. 2024

Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
Department of Neuroscience and Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, 0000, P.R. China.

BACKGROUND As one major symptom of Alzheimer's disease (AD), anterograde amnesia describes patients with an inability in new memory formation. The crucial role of the entorhinal cortex in forming new memories has been well established, and the neuropeptide cholecystokinin (CCK) is reported to be released from the entorhinal cortex to enable neocortical associated memory and long-term potentiation. Though several studies reveal that the entorhinal cortex and CCK are related to AD, it is less well studied. It is unclear whether CCK is a good biomarker or further a great drug candidate for AD. METHODS mRNA expressions of CCK and CCK-B receptor (CCKBR) were examined in two mouse models, 3xTg AD and CCK knock-out (CCK-/-) mice. Animals' cognition was investigated with Morris water maze, novel object recognition test and neuroplasticity with in-vitro electrophysiological recording. Drugs were given intraperitoneally to animals to investigate the rescue effects on cognitive deficits, or applied to brain slices directly to explore the influence in inducement of long-term potentiation. RESULTS Aged 3xTg AD mice exhibited reduced CCK mRNA expression in the entorhinal cortex but reduced CCKBR expression in the neocortex and hippocampus, and impaired cognition and neuroplasticity comparable with CCK-/- mice. Importantly, the animals displayed improved performance and enhanced long-term potentiation after the treatment of CCKBR agonists. CONCLUSIONS Here we provide more evidence to support the role of CCK in learning and memory and its potential to treat AD. We elaborated on the rescue effect of a promising novel drug, HT-267, on aged 3xTg AD mice. Although the physiological etiology of CCK in AD still needs to be further investigated, this study sheds light on a potential pharmaceutical candidate for AD and dementia.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017774 Long-Term Potentiation A persistent increase in synaptic efficacy, usually induced by appropriate activation of the same synapses. The phenomenological properties of long-term potentiation suggest that it may be a cellular mechanism of learning and memory. Long Term Potentiation,Long-Term Potentiations,Potentiation, Long-Term,Potentiations, Long-Term

Related Publications

Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
May 1993, European journal of pharmacology,
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
January 2005, Alcohol and alcoholism (Oxford, Oxfordshire),
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
January 2019, Journal of Alzheimer's disease : JAD,
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
January 1997, Gastroenterology,
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
June 2003, Pharmacogenetics,
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
January 1996, Journal of neural transmission (Vienna, Austria : 1996),
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
January 2020, Journal of Alzheimer's disease : JAD,
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
October 2005, The Japanese journal of physiology,
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
January 1980, Neuropsychologia,
Nan Zhang, and Yixuan Sui, and Peter Jendrichovsky, and Hemin Feng, and Heng Shi, and Xu Zhang, and Shenghui Xu, and Wenjian Sun, and Huatang Zhang, and Xi Chen, and Micky D Tortorella, and Jufang He
January 2020, Current Alzheimer research,
Copied contents to your clipboard!